Horizon Surgical Systems, Inc. is a medical robotics company developing AI-supported and robotics-enabled surgical platforms for ophthalmology. Founded in 2021 by experts in ophthalmology and medical robotics, the company is focused on procedures such as cataract surgery, applying micro-robotic control and AI-driven visualization to improve precision and consistency in eye surgery.
The company's flagship product, Polaris™, is described as the first AI-supported and robotics-enabled surgical platform purpose-built for ophthalmology. A first-in-human study has been completed in which 10 patients underwent robotic-assisted cataract surgery using the system.
Horizon Surgical Systems raised $30 million in Series A financing to advance its technology. The company operates across technical domains including surgical robotics, medical robotics, and micro-robotic control, with an industry focus spanning ophthalmology, microsurgery, and medical devices.
